Related Experiment Video
Updated: May 23, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Fasting APO B48 levels are associated with microalbuminuria in patients with type 2 diabetes
E Lapice1, P Cipriano, L Patti
1Department of Clinical and Experimental Medicine, University of Naples Federico II, Italy. emanuela1978@hotmail.it
Abstract:
In view of the high incidence of macrovascular diseases in patients with type 2 diabetes mellitus and microalbuminuria, the study evaluates the association of microalbuminuria with fasting plasma Apo B48 levels, a marker of the residual presence of intestinally derived TRLs lipoproteins, thought to be highly atherogenic. We studied 50 patients with type 2 diabetes aged 35-75 years. Exclusion criteria were overt macrovascular disease, overt nephropathy (Glomerular filtration rate (GFR) <45 ml/min/1.73 m(2)), or use of hypolipidemic agents. Anthropometry, fasting plasma lipids, plasma creatinine, and HbA1c were measured. Urinary albumin excretion was measured on a morning urine sample with the ELISA and expressed as albumin/creatinine ratio. GFR was estimated using the MDRD formula. The plasma fasting Apo B48 was measured by ELISA. Age, gender distribution, fasting plasma lipids, HbA1c, smoking status, plasma creatinine, estimate GFR, and the proportion of patients treated with insulin or antihypertensive drugs were similar for patients with or without microalbuminuria. People with microalbuminuria had longer diabetes duration (borderline significance) and significantly higher Apo B48 (1.765 ± 1.379 μg/ml vs. 1.022 ± 0.692 μg/ml, p = 0.01) than those without microalbuminuria. Multivariate logistic regression analysis confirmed that fasting Apo B48 levels were significantly associated with microalbuminuria independent of major confounders measured in the study. In patients with type 2 diabetes, microalbuminuria is associated with elevated Apo B48 levels, independent of major confounders; this may partly explain the excess cardiovascular risk of these patients.
Insights
Microalbuminuria in type 2 diabetes is linked to higher Apo B48 levels, a marker of atherogenic lipoproteins. This association may explain increased cardiovascular risk in these patients.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Nephrology
Background:
- Type 2 diabetes mellitus (T2DM) patients with microalbuminuria face high macrovascular disease risk.
- Microalbuminuria indicates early kidney damage and is a marker for cardiovascular complications.
- Apolipoprotein B48 (Apo B48) is a marker for intestinally derived triglyceride-rich lipoproteins (TRLs), considered highly atherogenic.
Purpose of the Study:
- To investigate the association between microalbuminuria and fasting plasma Apo B48 levels in T2DM patients.
- To determine if Apo B48 levels are an independent risk factor for microalbuminuria in T2DM.
- To explore the potential role of elevated Apo B48 in the excess cardiovascular risk observed in T2DM patients with microalbuminuria.
Main Methods:
- A study involving 50 T2DM patients (aged 35-75) without overt macrovascular disease or nephropathy.
- Measurements included anthropometry, fasting plasma lipids, HbA1c, creatinine, estimated GFR, and urinary albumin/creatinine ratio.
- Fasting plasma Apo B48 levels were quantified using ELISA.
Main Results:
- Patients with microalbuminuria exhibited significantly higher fasting Apo B48 levels compared to those without (1.765 ± 1.379 μg/ml vs. 1.022 ± 0.692 μg/ml, p = 0.01).
- Microalbuminuria was associated with longer diabetes duration (borderline significance).
- Multivariate logistic regression confirmed that elevated Apo B48 levels were significantly associated with microalbuminuria, independent of major confounders.
Conclusions:
- Microalbuminuria in T2DM patients is independently associated with elevated fasting Apo B48 levels.
- Increased Apo B48 may contribute to the heightened cardiovascular risk in T2DM patients with microalbuminuria.
- Targeting Apo B48-containing lipoproteins could be a strategy to mitigate cardiovascular risk in this population.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Nephropathy
Hyperglycemia
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...